Identification of the cleavage site involved in production of plasma soluble Fc gamma receptor type III (CD16)

European Journal of Immunology

Volumn 28, Issue 7, 1998, Pages 2101-2107

  Galon, Jérôme ^a,e   Moldovan, Ioana ^b   Galinha, Annie ^a   Provost Marloie, Marie Annick ^a   Kaudewitz, Hubert ^c   Roman Roman, Sergio ^d   Fridman, Wolf Herman ^a   Sautès, Catherine ^a  

^a INSTITUT CURIE   (France)

^b Center of Immunology   (Romania)

^c Hewlett Packard GmbH   (Germany)

^d SANOFI   (France)

^e NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Amino acid sequence; Fc receptor; Metalloproteinase; Neutrophils

Indexed keywords

CD16 ANTIGEN; FC RECEPTOR; SERINE; VALINE;

AMINO TERMINAL SEQUENCE; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CARBOXY TERMINAL SEQUENCE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; NEUTROPHILS; RECEPTORS, IGG; SERINE PROTEINASE INHIBITORS; TETRADECANOYLPHORBOL ACETATE;

EID: 0031874696     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199807)28:07<2101::AID-IMMU2101>3.0.CO;2-W     Document Type: Article

References (23)

1. Hulett, M. D. and Hogarth, M. P., Molecular basis of the Fc receptor function. Adv. Immunol. 1994. 57: 1-127.
2. Ravetch, J. V. and Perussia, B., Alternative membrane forms of FcγRIII (CD16) on human NK cells and neutrophils: cell-type specific expression of two genes which differ in single nucleotide substitutions. J. Exp. Med. 1989. 17: 481-497.
3. Teillaud, J. L., Bouchard, C., Astier, A., Teillaud, C., Tartour, E., Michon, J., Galinha, A., Moncuit, J., Mazières, N. Spagnoli, R., Fridman, W. H. and Sautès, C., Natural and recombinant soluble low-affinity FcγR: detection, purification, and functional activities. Immunomethods 1994. 4: 48-64.
4. Huizinga, T. W., de Haas, M., Kleijer, M., Nuijens, J. H., Roos, D. and von dem Borne, A. E., Soluble Fcγ receptor III in human plasma originates from release by neutrophils. J. Clin. Invest 1990. 86: 416-423.
5. Bazil, V. and Strominger, J. L., Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. Induction of cleavage of L-selectin via CD16. J. Immunol. 1994. 152: 1314-1322.
6. Tosi, M. F. and Zakem, H., Surface expression of Fc gamma receptor III (CD16) on chemoattractantstimulated neutrophils is determined by both surface shedding and translocation from intracellular storage compartments. J. Clin. Invest. 1992. 90: 462-470.
7. Barret, A. J., Classification of peptidases. Methods Enzymol. 1994. 244: 1-15.
8. Miller, C. G. and Bailey, J. M., Expanding the scope of applications for C-terminal sequencing. Am. Biotechnol. Lab. 1995. 13: 36-40.
9. Tamm, A. and Schmidt, R., IgG Binding sites of human Feγ receptors. Int. Rev. Immunol. 1997. 16: 57-86.
10. Huizinga, T. W. J., Kuijpers, R. W. A. M., Kleijer, M., Schulpen, T. W. J., Cuijpers, H. T., Roos, D. and von dem Borne, A. E., Maternal neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. Blood 1990. 76: 1927-1932.
11. Cartron, J., Celton, J. L., Gane, P., Astier, A., Fridman, W. H., Boissinot, G. and Cartron, J. P., Iso-immune neonatal neutropenia due to an anti-Fc receptor III (CD16) antibody. Eur. J. Pediatr. 1992. 151: 438-441.
12. Gallea-Robache, S., Morand, V., Millet, S., Bruneau, J. M., Bhatnagar, N., Chouaib, S. and Roman-Roman, S., A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells. Cytokine 1997. 9: 340-346.
13. Middelhoven, P. J., Ager, A., Roos, D. and Verhoeven, A. J., Involvement of a metalloprotease in the shedding of human neutrophil FcγRIIIB. FEBS Lett. 1997. 414: 14-18.
14. Wolfsberg, T. G., Primakoff, P., Myles, D. G. and White, J. M., ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J. Cell Biol. 1995. 131: 275-278.
15. Huizingua, T. W. J., de Haas, M., van Oers, M. H. J., Vilem, H., van der Wouw, P. A., Moulijn, A., van Weezel, H., Roos, D. and von dem Borne, A. E., The plasma concentration of soluble Fc-gamma RIII is related to production of neutrophils. Br. J. Haematol. 1994. 8: 459-463.
16. Mathiot, C., Teillaud, J. L., Elmalek, M., Mosseri, V., Euller-Ziegler, L., Daragon, A., Grosbois, B., Michaux, J. L., Facon, T., Bernard, J. F., Duclos, B., Monconduit, M. and Fridman, W. H., Correlation between serum soluble CD16 (sCD16) levels and disease stage in patients with multiple myeloma. J. Clin. Immunol. 1993. 13: 41-48.
17. Mathiot, C., Mary, J. Y., Tartour, E., Facon, T., Monconduit, M., Grosbois, B., Pollet, J. P., Michaux, J. L., Euller-Ziegler, L., Sautès, C., Bataille, R. and Fridman, W. H., Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS). Br. J. Haematol. 1996. 95: 660-665.
18. Khayat, D., Soubrane, C., Andrieu, J. M., Visonneau, S., Eme, D., Tourani, J. M., Beldjord, K., Weil, M., Fernandez, E. and Jacquillat, C., Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factors. J. Infect. Dis. 1990. 161: 430-434.
19. Mathiot, C., Galon, J., Tartour, E., Teillaud, J. L., Facon, T., Bataille, R., Fridman, W. H. and Sautès, C., Soluble CD16 in plasma cell dyscrasias. Leuk. Lymphoma, in press.
20. Esposito-Farèse, M. E., Sautès, C., de la Salle, H., Latour, S., Bieber, T., de la Salle, C., Ohlmann, P., Fridman, W. H., Cazenave, J. P., Teillaud, J. L., Daëron, M., Bonnerot, C. and Hanau, D., Membrane and soluble FcγRII/III modulate the antigen presenting capacity of murine dendritic epidermal Langerhans cells for IgG-complexed antigens. J. Immunol. 1995. 155: 1725-1736.
21. Gachet, C., Astier, A., de la Salle, H., de la Salle, C., Fridman, W. H., Cazenave, J. P., Hanau, D. and Teillaud, J. L., Release of FcγRIIa2 by activated platelets and inhibition of anti-CD9-mediated platelet aggregation by recombinant FcγRIIa2. Blood 1995. 85: 698-704.
22. Galon, J., Gauchat, J. F., Mazières, N., Spagnoli, R., Storkus, W., Lotze, M., Bonnefoy, J. Y., Fridman, W. H. and Sautès, C., Soluble Fcγ receptor type III (FcgRIII, CD16) triggers cell activation through interaction with complement receptors. J. Immunol. 1996. 157: 1184-1192.
23. Galon, J., Paulet, P., Galinha, A., Lorès, P., Bonnerot, C., Jami, J., Fridman, W. H. and Sautès, C., Soluble Feγ receptors: Interaction with ligands and functional consequences. Int. Rev. Immunol. 1997. 16: 87-112.